Market Research Reports
1. China Osteoporosis Market Introduction
 
2. China Osteoporosis Market Size by Number of People Suffering from Osteoporosis, 2007-2012
 
3. China Osteoporosis Drug Market Size and Introduction, 2007-2012
 
4. China Osteoporosis Drug Market Segmentation, 2007-2012
4.1. China Teriparatide Drug Market Size and Introduction, 2007-2012
4.2. China Teriparatide Drug Market Future Outlook and Projections, 2013-2017
4.3. China Bisphosphonates Drug Market Size and Introduction, 2007-2012
4.4. China Bisphosphonates Drug Market Future Outlook and Projections, 2013-2017
4.5. China Traditional Chinese Medicine Market Size and Introduction, 2007-2012
4.6. China Traditional Chinese Medicine Market Future Outlook and Projections, 2013-2017
4.7. China Calcitonin Drug Market Size and Introduction, 2007-2012
4.8. China Calcitonin Drug Market Future Outlook and Projections, 2013-2017
4.9. China Strontium Ranelate Drug Market Size and Introduction, 2007-2012
4.10. China Strontium Ranelate Drug Market Future Outlook and Projections, 2013-2017
4.11. China SERM Drug Market Size and Introduction, 2007-2012
4.12. China SERM Drug Market Future Outlook and Projections, 2013-2017
 
5. Market Share of Major Players in the China Osteoporosis Drugs Market, 2012
 
6. Company Profiles of Major Players in the China Osteoporosis Drugs Market
6.1. Novartis
Company Overview
Financial Performance
Business Strategies
6.2. Eli Lilly and Company
Company Overview
Financial Performance
Business Strategies
6.3. Merck
Company Overview
Financial Performance
Business Strategies
6.4. Tongjitang Chinese Medicines Co- TCM
Company Overview
Financial Performance
Business Strategy
 
7. China Osteoporosis Drugs Market Future Outlook and Projections, 2013-2017
 
8. China Osteoporosis Fracture Surgery Market Size and Introduction, 2007-2012
 
9. China Osteoporosis Fracture Surgery Market Segmentation, 2007-2012
9.1. China Vertebral Fracture Surgery Market Introduction and Size, 2007-2012
9.2. China Vertebral Fracture Surgery Market Future Outlook and Projections, 2013-2017
9.3. China Hip Fracture Surgery Market Size and Introduction, 2007-2012
9.4. China Hip Fracture Surgery Market Future Outlook and Projections, 2013-2017
 
10. China Osteoporosis Fracture Surgery Market Future Outlook and Projections, 2013-2017
 
11. China Osteoporosis Diagnostic Services Market Size and Introduction, 2006-2012
 
12. China Osteoporosis Diagnostic Services Market Segmentation, 2007-2012
12.1. China DXA Scans Market Size and Introduction, 2007-2012
12.2. China DXA Scans Future Outlook and Projections, 2013-2017
12.3. China QUS Market Size and Introduction, 2007-2012
12.4. China QUS Scans Market Future Outlook and Projections, 2013-2017
 
13. China Osteoporosis Diagnostic Services Market Future Outlook and Projections, 2013-2017
 
14. China Osteoporosis Diagnosis Equipment Market
14.1. DXA Equipment Market
14.2. Qus Equipment Market
 
15. China Osteoporosis Market Trends and Developments
Low Calcium Intake
Complex procedures replaced by Minimal Invasive Surgery
Generic Drugs Replacing the Patented Drugs
Government Health care Initiatives
 
16. China Osteoporosis Market Future Outlook and Projections, 2013-2017
16.1. Cause and Effect Relationship between Dependent and Independent Factors Prevailing in the China Osteoporosis Market
 
17. China Osteoporosis Market Government Policies and Initiatives
 
18. Hong Kong Osteoporosis Market
 
19. Taiwan Osteoporosis Market
 
20. Macro Economic Indicators for China Osteoporosis Market, 2007-2017
20.1. Rising Ageing Population, 2007-2017
20.2. Rising Healthcare Expenditure, 2007-2017
20.3. Increasing Household Consumption Expenditure, 2007-2017
20.4. Health Insurance Premium, 2007-2017
 
21. Appendix
21.1. Market Definitions
21.2. Abbreviations
21.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent) 
Multi Factor Based Sensitivity Model
Final Conclusion
21.4. Disclaimer
China Osteoporosis Market- Introduction and Market Size Pages : 7 USD 100    Market Size Reports Market Size Reports

  1. China Osteoporosis Market Introduction

Table 1: World Health Organization Criteria for Osteoporosis
2. China Osteoporosis Market Size by Number of People Suffering from Osteoporosis, 2007-2012
Figure 1: China Osteoporosis Market Size by Population Suffering From Osteoporosis in Million, 2007-2012
3. China Osteoporosis Drug Market Size and Introduction, 2007-2012
Figure 2: China Osteoporosis Drug Market Size on the Basis of Revenue in USD Million, 2007-2012

China Osteoporosis Market- Drug Market Segmentation Pages : 34 USD 250    Market Size Reports Market Size Reports

 4. China Osteoporosis Drug Market Segmentation, 2007-2012

Table 2: China Osteoporosis Drug Market Segmentation by Teriparatide, Bisphosphonate, Traditional Chinese Medicine, Calcitonin, Strontium Ranelate and SERM on the Basis of Revenue in Percentage (%) Million, 2007-2012
4.1. China Teriparatide Drug Market Size and Introduction, 2007-2012
Figure 3: China Teriparatide Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
Table 3: China Teriparatide Drug Market Size on the Basis of Revenue in USD Million, 2007-2012 27
4.2. China Teriparatide Drug Market Future Outlook and Projections, 2013-2017
Figure 4: China Teriparatide Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Table 4: China Teriparatide Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
4.3. China Bisphosphonates Drug Market Size and Introduction, 2007-2012
Figure 5: China Bisphosphonate Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
Table 5: China Alendronate Drug Market Size on the Basis of Revenue in USD Million, 2007-2012 32
Table 6: China Zoledronic Acid Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
4.4. China Bisphosphonates Drug Market Future Outlook and Projections, 2013-2017
Figure 6: China Bisphosphonate Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Table 7: China Alendronate Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Table 8: China Zoledronic Acid Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
4.5. China Traditional Chinese Medicine Market Size and Introduction, 2007-2012
Table 9: China Xianling Gubao Number of Formulary Hospitals, 2006-2008
Table 10: China Xianling Gubao Formulary Class 3 Hospitals as Percentage of Total Class 3 Hospitals, 2006-2008
Table 11: Number of Xianling Gubao Stocking Retail Pharmacies and Xianling Gubao Stocking Retail Authorized Pharmacies under the National Medical Insurance Program in China in Units, 2006-2008
Figure 7: China Traditional Chinese Medicine Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
Table 12: China Traditional Chinese Medicine (Xianling Gubao) Market Size on the Basis of Revenue in USD Million, 2007-2012
4.6. China Traditional Chinese Medicine Market Future Outlook and Projections, 2013-2017
Figure 8: China Traditional Chinese Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Table 13: China Traditional Chinese Medicine Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
4.7. China Calcitonin Drug Market Size and Introduction, 2007-2012
Figure 9 : China Calcitonin Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
Table 14: China Calcitonin Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
4.8. China Calcitonin Drug Market Future Outlook and Projections, 2013-2017
Figure 10: China Calcitonin Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Table 15: China Calcitonin Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
4.9. China Strontium Ranelate Drug Market Size and Introduction, 2007-2012
Figure 11: China Strontium Ranelate Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
Table 16: China Strontium Ranelate Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
4.10. China Strontium Ranelate Drug Market Future Outlook and Projections, 2013-2017
Figure 12: China Strontium Ranelate Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Table 17: China Strontium Ranelate Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
4.11. China SERM Drug Market Size and Introduction, 2007-2012
Figure 13: China SERM (Raloxifene) Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
Table 18: China SERM (Raloxifene) Drug Market Size on the Basis of Revenue in USD Million, 2007-2012
4.12. China SERM Drug Market Future Outlook and Projections, 2013-2017
Figure 14: China SERM (Raloxifene) Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Table 19: China SERM (Raloxifene) Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
 

China Osteoporosis Market- Drugs Market Share, Profile, Forecast Pages : 12 USD 150    Market Size Reports Market Size Reports

 5. Market Share of Major Players in the China Osteoporosis Drugs Market, 2012

Figure 15: Market Share of Major Players in China Osteoporosis Drugs Market, 2012
6. Company Profiles of Major Players in the China Osteoporosis Drugs Market
6.1. Novartis
Company Overview
Figure 16: Novartis Associates by Region, 2012
Table 20: List of Therapeutic Areas of Novartis
Financial Performance
Figure 17: Novartis Sales Revenue in USD Million, 2010-2012
Business Strategies
6.2. Eli Lilly and Company
Company Overview
Financial Performance
Figure 18: Eli Lilly and Company Sales Revenue in USD Million, 2007-2012
Table 21: Eli Lilly and Company Sales Revenue in USD Million, 2007-2012 64
Business Strategies
6.3. Merck
Company Overview
Financial Performance
Figure 19: Merck Sales Revenue in USD Million, 2007-2012
Business Strategies
6.4. Tongjitang Chinese Medicines Co- TCM
Company Overview
Financial Performance
Figure 20: Tongjitang (Xianling Gubao) Sales Revenue in USD Million, 2006-2008
Business Strategy
7. China Osteoporosis Drugs Market Future Outlook and Projections, 2013-2017
Figure 21: China Osteoporosis Drug Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
 

China Osteoporosis Market- Osteoporosis Fracture Surgery Market Pages : 13 150    Market Size Reports Market Size Reports

 8. China Osteoporosis Fracture Surgery Market Size and Introduction, 2007-2012

Figure 22: China Fracture Surgery Market Size on the Basis of Revenue in USD Million, 2007-2012
9. China Osteoporosis Fracture Surgery Market Segmentation, 2007-2012
Figure 23: China Fracture Surgery Market Segmentation by Vertebral Fractures and Hip Fractures on the Basis of Revenue in Percentage (%), 2007-2012
9.1. China Vertebral Fracture Surgery Market Introduction and Size, 2007-2012
Figure 24: China Vertebral Fracture Surgery Market Size on the Basis of Revenue in USD Million, 2007-2012
Table 22: China Vertebral Fracture Incidences in Units, 2007-2012
9.2. China Vertebral Fracture Surgery Market Future Outlook and Projections, 2013-2017
Figure 25: China Vertebral Fracture Surgery Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
9.3. China Hip Fracture Surgery Market Size and Introduction, 2007-2012
Figure 26: China Hip Fracture Surgery Market Size on the Basis of Revenue in USD Million, 2007-2012
Table 23: China Hip Fracture Incidences in Units and Estimated Hip Fracture Direct Cost in USD, 2007-2012
Table 24: China Hip Fracture Treatment Cost Comparison with Other Major Diseases in USD, 2007
Table 25: China Hip Fracture Incidences (Per 100,000) Among Men and Women Compared with Other Major Countries
9.4. China Hip Fracture Surgery Market Future Outlook and Projections, 2013-2017
Figure 27: China Hip Fracture Surgery Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
10. China Osteoporosis Fracture Surgery Market Future Outlook and Projections, 2013-2017
Figure 28: China Fracture Surgery Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
 

China Osteoporosis Market- Osteoporosis Diagnostic Services Market Pages : 8 USD 100    Market Size Reports Market Size Reports

 11. China Osteoporosis Diagnostic Services Market Size and Introduction, 2006-2012

Figure 29: Osteoporosis Self Assessment Tool for Asians
Figure 30: China Diagnostic Services Market Size on the Basis of Revenue in USD Million, 2007-2012
12. China Osteoporosis Diagnostic Services Market Segmentation, 2007-2012
Figure 31: China Diagnostic Services Market Segmentation by DXA Scans and QUS Scans on the Basis of Revenue in Percentage (%), 2007-2012
12.1. China DXA Scans Market Size and Introduction, 2007-2012
Table 26: Number of Available DXA Machines in Various Asian Countries in Units, 2008
Figure 32: China DXA Scans Market Size on the Basis of Revenue in USD Million, 2007-2012
12.2. China DXA Scans Future Outlook and Projections, 2013-2017
Figure 33: China DXA Scans Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
12.3. China QUS Market Size and Introduction, 2007-2012
Figure 34: China QUS Scans Market Size on the Basis of Revenue in USD Million, 2007-2012
12.4. China QUS Scans Market Future Outlook and Projections, 2013-2017
Figure 35: China QUS Scans Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
13. China Osteoporosis Diagnostic Services Market Future Outlook and Projections, 2013-2017
Figure 36: China Diagnostic Services Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
 

China Osteoporosis Market- Osteoporosis Diagnosis Equipment market Pages : 4 USD 50    Market Size Reports Market Size Reports

 14. China Osteoporosis Diagnosis Equipment Market

14.1. DXA Equipment Market
Table 27: China DXA Equipment Market Size by Number of Machines in Units, 2008 and 2012
14.2. Qus Equipment Market
Table 28: Recommendations for BMD Testing by DXA following QUS Test
Table 29: China QUS Equipment Market Size by Number of Machines in Units, 2008 and 2012 97
Table 30: China Bone Densitometry Machine Suppliers
 

China Osteoporosis Market- Trends, Forecast and Govt Policies Pages : 6 USD 100    Market Size Reports Market Size Reports

 15. China Osteoporosis Market Trends and Developments

16. China Osteoporosis Market Future Outlook and Projections, 2013-2017
Figure 37: China Osteoporosis Market Future Projections on the Basis Population Suffering from Osteoporosis in Million, 2013-2017 1
16.1. Cause and Effect Relationship between Dependent and Independent Factors Prevailing in the China Osteoporosis Market
Table 31: Cause and Effect Relationship Analysis between Industry Factors and Expected Industry Prospects of China Osteoporosis Market
17. China Osteoporosis Market Government Policies and Initiatives
 

China Osteoporosis Market- Hong Kong and Taiwan Market Pages : 5 USD 50    Market Size Reports Market Size Reports

 18. Hong Kong Osteoporosis Market

Table 33: Hong Kong Incidence Rate of Hip Fractures (per 100,000 population), 1966, 1985, 2001 and 2006
Table 34: Hong Kong Age Specific Fracture (Per 100,000) for Women, 2004
Table 35: Hong Kong Mean Annual Cost of Fracture and Treatment per Patient in USD, 2009
Table 36: One Way Sensitivity Analysis of Different Drugs in Women Aged 70 years in USD, 2009
19. Taiwan Osteoporosis Market
Table 37: Taiwan Hip Fracture and Treatment Cost in USD Million, 2006
Table 38: Taiwan DXA and QUS Machine Penetration in Units (Per 10000 population) and Scan Cost (In USD), 2006
 

China Osteoporosis Market- Macro Economy Pages : 5 USD 50    Market Size Reports Market Size Reports

20. Macro Economic Indicators for China Osteoporosis Market, 2007-2017

20.1. Rising Ageing Population, 2007-2017

Figure 38: China Ageing (50 years and above) Population in Million, 2007-2017

20.2. Rising Healthcare Expenditure, 2007-2017

Figure 39: China Health Care Expenditure in USD Million, 2007-2017

20.3. Increasing Household Consumption Expenditure, 2007-2017

Figure 40: China Rising Household Final Consumption Expenditure in USD Million, 2007-2017

20.4. Health Insurance Premium, 2007-2017

Figure 41: China Health Insurance Premium in USD Million, 2007-2017